Announcements

C4 Therapeutics, Inc. (NASDAQ:CCCC) filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 11, 2026.

Sagimet Biosciences Inc. filed a current report on Form 8-K with the SEC on August 11, 2026, disclosing its financial results for the quarter ended June 30, 2026, and furnishing an updated investor presentation.

Zura Bio Limited filed a Form 8-K with the U.S. Securities and Exchange Commission on August 11, 2026, disclosing its second quarter 2026 financial results via press release and an updated corporate presentation.

DPC Holdings PLC filed its Form 10-Q for the quarterly period ended June 28, 2026 with the U.S. Securities and Exchange Commission, reporting a net loss of $131.1 million for the three months ended June 28, 2026 and disclosing proceeds from its initial public …

Theravance Biopharma, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 11, 2026, covering the period ended June 30, 2026, and disclosing a net loss of $10.831 million for the first half of the year alongside …

Smithfield Foods, Inc. filed its Form 10-Q for the quarterly period ended June 28, 2026 with the U.S. Securities and Exchange Commission on August 11, 2026, disclosing income statements, balance sheet data, and cash flow results for the three and six months ended June …

Prelude Therapeutics Incorporated filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission, reporting its first period of recognized revenue alongside a narrowed net loss compared to the prior year.